Telaglenastat
N/A
Report date: 2026/04/08 20:02:35
NME
Base Information
Drug NameTelaglenastat
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[27]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[8]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCalithera Biosciences Inc
China Registration ClassN/A
Develop Information
Active CompaniesSynhale Therapeutics IncWashington University School Of MedicineUniversity Of Pittsburgh +[7]
Inactive CompaniesUniversity Of Alabama At Birmingham
Active Indications +[12]
Inactive Indications +[15]
Other Information
ATC CodeN/A
Related LinksN/A